Long-term safety follow-up of CTX0E03 in people who had ischemic stroke
Follows people with ischemic stroke who got CTX0E03 to watch for delayed side effects.
Plain-language title generated from the registry record
Registry title: Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
Key facts
- Where
- Morgantown, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 75 years old?
Source: NCT05598775, who can take part
Where in United States
- Amy Miller, RPh, PharmDMorgantown, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- ReNeuron Limited
- Trial code
- NCT05598775
- Record updated
- 31 March 2023
- Original description
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survivalRead full original descriptionShow less
Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival
Inclusion: Subjects who have received CTX0E03 DP as part of the active arm in the PISCES III study Have provided appropriate written informed consent.
Exclusion: None.